Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuraxis (NRXS) Equity Average (2023 - 2025)

Historic Equity Average for Neuraxis (NRXS) over the last 3 years, with Q3 2025 value amounting to $3.3 million.

  • Neuraxis' Equity Average rose 19271.05% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 19271.05%. This contributed to the annual value of $332253.5 for FY2024, which is 10952.45% up from last year.
  • Per Neuraxis' latest filing, its Equity Average stood at $3.3 million for Q3 2025, which was up 19271.05% from $2.3 million recorded in Q2 2025.
  • Neuraxis' 5-year Equity Average high stood at $3.3 million for Q3 2025, and its period low was -$5.5 million during Q3 2023.
  • For the 3-year period, Neuraxis' Equity Average averaged around -$1.1 million, with its median value being -$1.2 million (2023).
  • Its Equity Average has fluctuated over the past 5 years, first soared by 3624.21% in 2024, then soared by 19271.05% in 2025.
  • Over the past 3 years, Neuraxis' Equity Average (Quarter) stood at -$1.2 million in 2023, then skyrocketed by 111.11% to $136908.0 in 2024, then surged by 2287.82% to $3.3 million in 2025.
  • Its Equity Average stands at $3.3 million for Q3 2025, versus $2.3 million for Q2 2025 and $1.2 million for Q1 2025.